Clinical Trials Logo

Clinical Trial Summary

Spontaneous reports by health professionals generate the signals in pharmacovigilance. However, the passive method has limitations and the most important of them are the underreporting and the poor quality of data, hindering the causality assessment of adverse drug events (ADE). Therefore, the present study aimed to validate an educational intervention (EI) in pharmacovigilance for hospital health professionals, in order to analyze the impact on the knowledge, skill and attitude in ADE reporting. Investigators proposed a multifaceted EI which will be developed in four meetings with one hour each. The following activities will be carried out: application of a questionnaire to assess the knowledge, skill and attitude before and after EI; lecture; practical class and education material distribution. The answers of questionnaire are going to be analyzed using content analysis technique. The definitions of World Health Organization and the minimum and desired criteria to fill the ADE form, according to the Pan American Health Organization, are going to be considered gold-standard answers. The statistical test of Wilcoxon-Mann Whitney test for paired samples will be applied, in order to assess the impact of educational intervention on behavior of health professionals (ADE reporting). With the present study, the following hypotheses will be tested: H0= There is no difference between the numbers of ADE reported (behavior/attitudes) before and after the educational intervention. H1= The numbers of ADE reported before and after the educational intervention are different.


Clinical Trial Description

A quasi-experimental study with health professionals who acted in a general and public hospital of medium complexity with 104 beds will be performed. Investigators proposed an educational intervention, with the development of lecture and practical class, application of questionnaire before and after EI and the distribution of educational material. Activities will be developed in four meetings of one hour each one. In the first meeting, questionnaire will be applied, in order to assess knowledge, skills and attitudes in pharmacovigilance prior to EI. The instrument was elaborated based on previous studies. Second meeting will be comprise a lecture regarding the theoretical framework and importance of pharmacovigilance, and distribution of educational material, whose content includes the same issues of presentation. In the third meeting, a practical class will be performed to promote a discussion of a fictitious case of adverse drug reaction (ADR), in order to elucidate the correct fill of ADE form. In the fourth meeting, will be repeated the application of questionnaire, in order to assess the impact of EI. With the aim to verify change behavior of health professionals regarding pharmacovigilance activities, the number of ADE reports made prior and after intervention will be compared. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02134587
Study type Interventional
Source Universidade Estadual Paulista Júlio de Mesquita Filho
Contact
Status Completed
Phase N/A
Start date February 2012
Completion date May 2014

See also
  Status Clinical Trial Phase
Suspended NCT02559960 - Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Completed NCT01946919 - Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Recruiting NCT04154553 - Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
Completed NCT01732302 - Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients N/A
Completed NCT05224804 - Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals
Completed NCT02297126 - A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program N/A
Completed NCT03093818 - PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions N/A
Not yet recruiting NCT04568668 - Evaluating ActionADE in Reducing Adverse Drug Reactions N/A
Recruiting NCT02012504 - Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients Phase 0
Completed NCT01872520 - Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study N/A
Completed NCT01467050 - Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients Phase 4
Completed NCT01679964 - Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study Phase 4
Completed NCT02094638 - Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study N/A
Recruiting NCT01906710 - the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes N/A
Completed NCT02888834 - Serious Adverse Drug Reaction and Their Preventability N/A
Completed NCT02838212 - Adverse Drug Reactions With Fatal Outcome N/A
Completed NCT02159209 - The Drug Induced Renal Injury Consortium N/A
Completed NCT04553107 - Reducing Costs by Deprescribing Medications N/A
Recruiting NCT06219720 - The Texas Interprofessional Pharmacogenomics (IPGx)
Recruiting NCT05508763 - Personalised Therapeutics @LUMC